In the evolution of a Quant-based portfolio, there comes a moment where "cheap" is no longer enough. For years, my Augmented Income Strategy (AIS) was a pure game of Mean Reversion: if a high-quality ticker dropped below its -1.05 Standard Deviation (StDev) target, it was a buy. It was simple, effective, and sometimes—painfully—early.
Today, I am marking a fundamental shift in my capital allocation. I am moving liquidity out of the "parking lot" of High-Yield Savings Accounts (HYSA) and into a specific income asset: Sempra 5.75% Junior Subordinated Notes due 2079 (SREA).
What makes this purchase different isn't just the asset; it’s the Multi-Layered Filtering now driving my decisions.
The Logic Shift: Merging AIS with MAS
Historically, I reserved my "Trend and Momentum" metrics (MAS Strategy) for growth stocks. But as market volatility has increased, I’ve realized that income seekers can no longer afford to "catch falling knives."
I have now applied the 30/90-Day EMA Filter to my income plays. The goal? To find the "Sweet Spot" where deep value meets a confirmed reversal.
My new criteria for an AIS entry requires a "Tuple" of three specific conditions:
StDev Decline: The price must be selling below its target valuation (Mean Reversion).
The 30-Day Floor: The price must have crossed Above the 30-day EMA. This proves that the short-term bleeding has stopped and market participants are buying back in.
The 90-Day Ceiling: The price must remain Below the 90-day EMA. This ensures I am still buying at a long-term discount, not chasing a "hyped" peak.
Why SREA? (Sempra FXD NT 79)
Sempra is a utility giant I already trust; I own the common stock (SRE). However, SREA offers a different risk-reward profile that perfectly fits my current income goals.
Security Over Common: As a Junior Subordinated Note, SREA sits higher in the capital structure than my SRE common shares. While the dividend is not "qualified" (taxed as interest), the stability of the payment is backed by the contractual obligations of a utility powerhouse.
The "Double Gain" (Yield + Par): At a current price near $21.71, I am locking in a yield significantly higher than my HYSA. But there is a hidden kicker: The Par Value. These notes are scheduled to be redeemed at $25.00 in 2079. Whether it is me or my beneficiaries holding the bag at the finish line, that $3.29 per share gap represents a ~15% capital gain on top of the quarterly income.
Missing the "Ex" but Catching the "Trend": I am executing this trade despite having just missed the ex-dividend date. In the old system, I might have waited. In the new system, the Above 30 / Below 90 signal is more valuable than a single quarterly check. I would rather buy a rising trend at $21.71 than a falling one at $21.50 just to "capture" a dividend.
The "Slower to Scale" Advantage
By applying this MAS-style momentum filter to my AIS picks, my system has become "Quantifiably Patient." I am no longer just a yield seeker; I am a yield technician. I am demanding that the market confirm the bottom before I commit my hard-earned HYSA cash.
In an era where "Competition Feedback" and earnings surprises can wipe out months of dividends in a single afternoon, this multi-layered approach is my firewall. I’m not just buying Sempra; I’m buying the reversal.
Disclosure: I am an individual investor, not a financial advisor. This post reflects my personal "Quant" strategy and current portfolio moves. Investing in Junior Subordinated Notes involves risks, including interest rate sensitivity and credit risk. Always perform your own due diligence or consult with a professional before moving capital out of insured accounts like HYSAs.